Efficacy of Antioxidant Treatment in Reducing Resistin Serum Levels: A Randomized Study
Open Access
- 4 May 2007
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLoS Clinical Trials
- Vol. 2 (5), e17
- https://doi.org/10.1371/journal.pctr.0020017
Abstract
Few in vitro studies have examined the participation of resistin, a recently discovered adipokine, in oxidative processes. We investigated whether in vivo treatment with the antioxidant vitamin C might affect resistin serum levels. Randomized prospective open trial. San Giovanni Battista Hospital, Turin, Italy. Eighty healthy individuals. Administration of 2 g of ascorbic acid orally for 2 wk (n = 40; experimental group) or no supplementation (n = 40; control group). The primary end point was the between-group difference in the before–after change in resistin serum level after vitamin C supplementation. Secondary endpoints were the within- and between-group changes in glucose, insulin, lipid parameters, C-reactive protein fasting values, and markers of oxidative stress. In the experimental group, vitamin C supplementation was significantly associated with both resistin concentration reduction (from 4.3 ± 1.5 to 2.9 ± 0.8 ng/ml; 95% confidence interval [CI] −1.87, −1.03) and ascorbic acid level increase (from 9.4 ± 2.9 to 19.0 ± 5.2 mg/l; 95% CI 7.9, 11.2). In the control group, resistin levels did not change significantly (from 4.2 ± 1.0 to 4.3 ± 0.9 ng/ml; 95% CI −0.07, 0.37). The between-group differences were highly significant (p < 0.001). Vitamin C supplementation was also associated with a statistically significant reduction in nitrotyrosine level and incremental increase in reduced glutathione. In a linear regression model, within-individual changes in vitamin C concentrations were inversely correlated with changes in resistin levels in both groups (each unit increase of vitamin C corresponded to a decrease of about 0.10 units of resistin levels (95% CI 0.13, 0.08; p < 0.001). This is to our knowledge the first randomized trial in humans that has demonstrated that short-term vitamin C supplementation could significantly reduce resistin levels, independent of changes in inflammatory or metabolic variables. Future investigations of resistin participation in oxidative processes are warranted. ClinicalTrials.gov NCT00387114Keywords
This publication has 42 references indexed in Scilit:
- Up-regulation of PTEN (Phosphatase and Tensin Homolog Deleted on Chromosome Ten) Mediates p38 MAPK Stress Signal-induced Inhibition of Insulin SignalingOnline Journal of Public Health Informatics, 2006
- Oxidative stress provokes atherogenic changes in adipokine gene expression in 3T3-L1 adipocytesBiochemical and Biophysical Research Communications, 2006
- Resistin is secreted from macrophages in atheromas and promotes atherosclerosisCardiovascular Research, 2006
- The potential role of resistin in atherogenesisAtherosclerosis, 2005
- An Inflammatory Cascade Leading to Hyperresistinemia in HumansPLoS Medicine, 2004
- Resistin Promotes Smooth Muscle Cell Proliferation Through Activation of Extracellular Signal–Regulated Kinase 1/2 and Phosphatidylinositol 3-Kinase PathwaysJournal of the American College of Cardiology, 2004
- Resistin is expressed in human macrophages and directly regulated by PPARγ activatorsBiochemical and Biophysical Research Communications, 2003
- Insulin Resistance and Type 2 Diabetes Are Not Related to Resistin Expression in Human Fat Cells or Skeletal MuscleBiochemical and Biophysical Research Communications, 2001
- FIZZ1, a novel cysteine-rich secreted protein associated with pulmonary inflammation, defines a new gene familyThe EMBO Journal, 2000
- Physiological Analysis of Middle-Aged and Old Former AthletesJournal of the American College of Cardiology, 1968